Loading...

New Cell Sources for T Cell Engineering and Adoptive Immunotherapy

The promising clinical results obtained with engineered T cells, including chimeric antigen receptor (CAR) therapy, call for further advancements to facilitate and broaden their applicability. One potentially beneficial innovation is to exploit new T cell sources that reduce the need for autologous...

Full description

Saved in:
Bibliographic Details
Published in:Cell Stem Cell
Main Authors: Themeli, Maria, Rivière, Isabelle, Sadelain, Michel
Format: Artigo
Language:Inglês
Published: 2015
Subjects:
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5611846/
https://ncbi.nlm.nih.gov/pubmed/25842976
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.stem.2015.03.011
Tags: Add Tag
No Tags, Be the first to tag this record!